<DOC>
	<DOCNO>NCT01272180</DOCNO>
	<brief_summary>This study evaluate safety immunogenicity combination vaccine compare reference vaccine</brief_summary>
	<brief_title>Safety Immunogenicity Different Meningitis Vaccine Formulations Adolescents Young Adults</brief_title>
	<detailed_description />
	<mesh_term>Meningococcal Infections</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Healthy adolescent age 10 25 year age inclusive time enrollment . History meningococcal vaccine administration ; Current previous , confirm suspected disease cause N. meningitidis ; Pregnant nursing ( breastfeed ) mother ; Females childbearing age use plan use acceptable birth control measure , duration study ; Any serious , chronic , progressive disease ; Known suspect impairment/alteration immune system ; Receipt blood , blood product and/or plasma derivative , parenteral immunoglobulin preparation within previous 90 day ; History severe allergic reaction previous vaccination hypersensitivity vaccine component .</criteria>
	<gender>All</gender>
	<minimum_age>10 Years</minimum_age>
	<maximum_age>25 Years</maximum_age>
	<verification_date>September 2014</verification_date>
	<keyword>Safety</keyword>
	<keyword>Immunogenicity</keyword>
	<keyword>Vaccine</keyword>
	<keyword>Meningococcal</keyword>
	<keyword>Seroresponse</keyword>
</DOC>